钙剂对老年肺炎并低血钙患者疗效及IL-2、IL-17的影响

发布时间：2018-03-18 21:16

本文选题：老年　切入点：社区获得性肺炎　出处：《现代预防医学》2014年19期 　论文类型：期刊论文

【摘要】：目的探讨钙剂治疗老年社区获得性肺炎并低血钙患者临床疗效及对IL-2、IL-17的影响。方法选取老年社区获得性肺炎并低血钙患者90例,采用随机数字表法分为常规组和钙剂治疗组,所有患者治疗前后均测定血清中IL-2、IL-17浓度,比较两组患者治疗前后血液指标变化及临床好转时间、并发症发生率、住院天数。结果两组患者治疗前,血清IL-2、IL-17水平无差别,治疗后两组患者血清IL-2水平较治疗前升高、IL-17水平降低,其中钙剂治疗组改变更为明显;钙剂治疗组较常规治疗组体温恢复至正常时间短、并发症发生率低、住院天数缩短,差异明显(P0.05)。结论钙剂可以改善患者气道炎症反应,提高机体抵抗力,增强患者临床治疗疗效。
[Abstract]:Objective to investigate the clinical effect of calcium in the treatment of elderly patients with community-acquired pneumonia complicated with hypocalcemia and its effect on IL-2.Methods 90 elderly patients with community-acquired pneumonia complicated with hypocalcemia were randomly divided into two groups: routine group and calcium treatment group. The serum levels of IL-17 in all patients were measured before and after treatment. The changes of blood indexes, the time of clinical improvement, the incidence of complications and the days of hospitalization were compared between the two groups before and after treatment. Results there was no difference in the level of IL-17 between the two groups before and after treatment. After treatment, the serum IL-2 level in both groups was lower than that before treatment, especially in the calcium treatment group, the body temperature in the calcium treatment group was shorter than that in the routine treatment group, the incidence of complications was lower, and the hospital stay was shorter. Conclusion calcium can improve airway inflammation, increase body resistance and enhance clinical therapeutic effect.
【作者单位】：河北联合大学附属医院呼吸科;
【分类号】：R563.1

【参考文献】